Ann: Clinical Trial Update, page-14

Probably sage words, thanks

Yes can definitely weigh but generally effects companies more when there is no medium term inflection points on the horizon.

In terms of market cap I just can’t see it dropping too much further. Having said that (and what I said) I already have a fairly decent (for me) position in the company and while I think I will still accumulate more it will be in a fairly patient kind of way.